Skip to main content

DocuSign's Life Sciences Modules for 21 CFR Part 11

Spend time on patients, not paperwork

Improve the patient, doctor and employee experience

Contact sales
A doctor reviews a document with a patient
A dropdown menu in DocuSign eSignature gives users options for why they are signing a document

Simplify compliance

Docusign offers modules to support your compliance with the electronic signature practices set forth in the USA. US Food and Drug Administration’s 21 CFR Part 11 Our core Part 11 module includes Part 11-specific eSignature functionality for authentication, reason for signature and signature manifestation. These capabilities help you comply with regulations while using eSignature to make executing agreements faster, more cost-efficient and more convenient for everyone involved.

Screenshot of an email from DocuSign containing a document for the recipient to review and sign

Validate signature processes

An additional module is the Docusign Validator for Life Sciences, which simplifies your validation testing and documentation required for Part 11 compliance. Its reports contain screenshots of each test, details of the specific provision tested, and the final results.

  • Account-wide controls

    Apply module settings to all envelopes sent from your account to enable consistent compliance.

  • Simplify compliance validation

    Receive automated reports regarding Part 11 functionality compliance.

  • Authenticate two ways

    Require two-factor authentication to access and sign documents.

  • Know who did what

    View a detailed audit trail and Certificate of Completion for each transaction.

FAQ

  • Life sciences organisations use Docusign to reduce time to market, simplify global collaboration, and improve the patient, doctor and employee experience.

  • See the support page for the Validator.

  • Our partner USDM provides technology and services that enable life science customers to achieve and maintain Part 11 compliance.

Get started today

Your patients are waiting.